FCM
TWST icon

Freshford Capital Management’s Twist Bioscience TWST Stock Holding History

Freshford Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Sell
177,449
-81,533
-31% -$5.31M 6.25% 3
2026
Q1 		$12.3M Sell
258,982
-161,189
-38% -$7.23M 6.15% 6
2025
Q4 		$13.3M Buy
+420,171
New +$13.1M 5.35% 10

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Freshford Capital Management's TWST Position: Q2 2026 in Review

Freshford Capital Management reduced its Twist Bioscience (TWST) stake by 31% in Q2 2026, selling an estimated $5.31M and leaving 177,449 shares worth $18.3M. The position accounts for 6.25% of the portfolio, ranked #3.

Freshford Capital Management first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Freshford Capital Management held 177,449 shares of Twist Bioscience worth $18.3M as of Q2 2026.
  • Freshford Capital Management sold 81,533 Twist Bioscience shares in Q2 2026, an estimated $5.31M.
  • Twist Bioscience made up 6.25% of Freshford Capital Management's portfolio in Q2 2026, its #3 holding.
  • Freshford Capital Management first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Freshford Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.